share_log

Altimmune | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TIAA-CREF Investment Management, LLC(2.88%),Teachers Advisors, LLC(0.32%), etc.

SEC announcement ·  Feb 14 12:07
Summary by Moomoo AI
On December 31, 2023, Altimmune Inc., a biopharmaceutical company, was the subject of a Schedule 13G filing with the Securities and Exchange Commission (SEC), indicating changes in ownership by significant investment entities. Nuveen Asset Management, LLC (NAM), TIAA-CREF Investment Management, LLC (TCIM), and Teachers Advisors, LLC (TAL), all based in Delaware, reported their respective holdings in Altimmune's common stock. NAM reported beneficial ownership of 6,679 shares, TCIM reported 1,549,364 shares, and TAL reported 171,273 shares, with all shares being acquired in the ordinary course of business. The combined holdings represent a total of 3.21% of Altimmune's common stock. The filing, dated February 14, 2024, confirms that the shares were not acquired with the intention of changing or influencing the control of Altimmune Inc. The principal executive offices of Altimmune Inc. are located at 910 Clopper Road, Suite 201S, Gaithersburg, MD, United States.
On December 31, 2023, Altimmune Inc., a biopharmaceutical company, was the subject of a Schedule 13G filing with the Securities and Exchange Commission (SEC), indicating changes in ownership by significant investment entities. Nuveen Asset Management, LLC (NAM), TIAA-CREF Investment Management, LLC (TCIM), and Teachers Advisors, LLC (TAL), all based in Delaware, reported their respective holdings in Altimmune's common stock. NAM reported beneficial ownership of 6,679 shares, TCIM reported 1,549,364 shares, and TAL reported 171,273 shares, with all shares being acquired in the ordinary course of business. The combined holdings represent a total of 3.21% of Altimmune's common stock. The filing, dated February 14, 2024, confirms that the shares were not acquired with the intention of changing or influencing the control of Altimmune Inc. The principal executive offices of Altimmune Inc. are located at 910 Clopper Road, Suite 201S, Gaithersburg, MD, United States.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more